Page 13 - Odds Ratio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(0) - Day 28 full results from the SAVE-MORE study show early treatment with anakinra plus SOC (standard of care) reduced mortality by 55% and reduced average time until ICU (intensive care unit) discharge by four days - Day 28 full results from the SAVE-MORE study show early treatment with anakinra plus SOC (standard of care) reduced mortality by 55% and reduced average time until ICU (intensive care unit) discharge by four days - In patients treated with anakinra plus SOC, overall clinical status improved by 64% compared to those treated with SOC alone - The SAVE-MORE trial, conducted by the Hellenic Institute for the Study of Sepsis, is the first large, pivotal randomised controlled trial to specifically evaluate a target patient population with COVID-19 at risk of progressing and demonstrating the benefit of earlier intervention with anakinra for the prevention of disease progression and reduced risk of mortality

United statesKostenloser wertpapierhandelMaria kruseEvangelosj giamarellos bourboulisPaula treutigerGuido oelkersEuropean shock societyWorld health organizationHellenic institute for the study of sepsisKapodistrian university of athensEuropean sepsis allianceHellenic instituteInternal medicineInfectious diseasesKapodistrian universityEuropean sepsis